Evidence map›Paper›PMID 41582419›Full record

ArticleBritish journal of haematology2026

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan.

Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Takafumi FurumotoUnit for Radiation Effects on Humans, Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Koji AndoUnit for Radiation Effects on Humans, Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Eo ToriyamaDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Tomoko HataDepartment of Clinical Laboratory, Nagasaki Harbor Medical Center, Nagasaki, Japan.
Hikaru SakamotoDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Masahiko ChiwataDepartment of Hematology, Japan Community Health Care Organization Isahaya General Hospital, Isahaya, Japan.
Hideaki KitanosonoDepartment of Hematology, Japan Community Health Care Organization Isahaya General Hospital, Isahaya, Japan.
Jun NakashimaDepartment of Hematology, Nagasaki Harbor Medical Center, Nagasaki, Japan.
Takeharu KatoDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Masataka TaguchiDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Makiko HoraiUnit for Radiation Effects on Humans, Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Hidehiro ItonagaTransfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
Shinya SatoDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Yasushi SawayamaDepartment of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
Daisuke ImanishiDepartment of Internal Medicine, Nagasaki Prefecture Gotochuoh Hospital, Goto, Japan.
Yoshitaka ImaizumiDepartment of Hematology, NHO Nagasaki Medical Center, Omura, Japan.
Tatsuro JoDepartment of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0001-5415-6228
Shinichiro YoshidaDepartment of Hematology, NHO Nagasaki Medical Center, Omura, Japan.
Yukiyoshi MoriuchiDepartment of Hematology, Sasebo City General Hospital, Sasebo, Japan.
Yasushi MiyazakiUnit for Radiation Effects on Humans, Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Funding

Japan Society for the Promotion of Science 25K11628Japan Society for the Promotion of Science JP22K08481
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

JapanMyelodysplastic syndromesOverall survivalPrognosisRetrospective study

Identifiers

PMID41582419
PMCPMC13071489

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.